Literature DB >> 1382988

Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas.

D A Fruman1, P E Mather, S J Burakoff, B E Bierer.   

Abstract

Ligation of T cell receptor/CD3 complexes induces programmed cell death, or apoptosis, in immature thymocytes and many T cell hybridomas. While it has been demonstrated that T cell receptor-mediated apoptosis requires an increase in intracellular calcium concentration, the specific calcium-dependent signalling events leading to cell death are poorly defined. We have previously shown that T cell receptor/CD3-mediated induction of apoptosis in a murine T cell hybridoma is inhibited by the immunosuppressive drugs cyclosporin A (CsA) and FK506. Recently, it has been determined that these agents inhibit the activity of calcineurin, a calcium- and calmodulin-dependent serine/threonine phosphatase. Using an assay which measures calcineurin activity in cell lysates, we find that calcineurin-dependent dephosphorylation of a phosphopeptide substrate is potently inhibited in hybridomas treated with CsA or FK506. Drug dose-response analyses indicate that the level of cellular calcineurin activity correlates closely with the ability of these cells to undergo apoptosis. Thus, calcineurin appears to be a critical mediator of T cell receptor/CD3 signalling leading to programmed cell death in T cell hybridomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382988     DOI: 10.1002/eji.1830221008

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Immunotoxic effects of exposure of rats to xenobiotics via maternal lactation. Part I 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  J S Badesha; G Maliji; B Flaks
Journal:  Int J Exp Pathol       Date:  1995-12       Impact factor: 1.925

Review 2.  Regulation of apoptosis in immune cells.

Authors:  J D Mountz; T Zhou; J Wu; W Wang; X Su; J Cheng
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

3.  pmp1+, a suppressor of calcineurin deficiency, encodes a novel MAP kinase phosphatase in fission yeast.

Authors:  R Sugiura; T Toda; H Shuntoh; M Yanagida; T Kuno
Journal:  EMBO J       Date:  1998-01-02       Impact factor: 11.598

4.  Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism.

Authors:  S P Butcher; D C Henshall; Y Teramura; K Iwasaki; J Sharkey
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

5.  Calcineurin-dependent nuclear translocation of a murine transcription factor NFATx: molecular cloning and functional characterization.

Authors:  J Liu; N Koyano-Nakagawa; Y Amasaki; F Saito-Ohara; T Ikeuchi; S Imai; T Takano; N Arai; T Yokota; K Arai
Journal:  Mol Biol Cell       Date:  1997-01       Impact factor: 4.138

6.  Characterization of a mutant calcineurin A alpha gene expressed by EL4 lymphoma cells.

Authors:  D A Fruman; S Y Pai; S J Burakoff; B E Bierer
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

7.  Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77.

Authors:  K Yazdanbakhsh; J W Choi; Y Li; L F Lau; Y Choi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

8.  Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.

Authors:  Anita Y M Chan; Vernon W Dolinsky; Carrie-Lynn M Soltys; Benoit Viollet; Shairaz Baksh; Peter E Light; Jason R B Dyck
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

9.  Role of Ca2+ in the intracellular signaling pathway of anti-IgM-induced apoptosis in the human B-cell line, MBC-1, established from Burkitt lymphoma.

Authors:  Masamune Higashigawa; Yoshihiro Komada
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

10.  Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis.

Authors:  Yasuko Hirakawa; Laura J Nary; Rheem D Medh
Journal:  J Mol Signal       Date:  2009-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.